Interestingly, apolipoprotein E (ApoE), which is the strongest genetic risk factor for AD, plays a role in the shift from the homeostatic M0 to DAM/MGnD phenotype, by activating the triggering receptor expressed on myeloid cells-2 (TREM2). The gene discussed is APOE; the disease is Alzheimer disease.